Rapid electrochemiluminoimmunoassay of human C-reactive protein at planar disposable oxide-coated silicon electrodes

被引:38
作者
Ala-Kleme, T [1 ]
Mäkinen, P
Ylinen, T
Väre, L
Kulmala, S
Ihalainen, P
Peltonen, J
机构
[1] Univ Turku, Dept Chem, FIN-20014 Turku, Finland
[2] Helsinki Univ Technol, Inorgan & Analyt Chem Lab, FIN-02015 Helsinki, Finland
[3] Abo Akad Univ, Dept Phys Chem, FIN-20500 Turku, Finland
关键词
D O I
10.1021/ac051157i
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Electrochemiluminescence (ECL) of aromatic Tb(III) chelates at thin insulating film-coated electrodes provides a means for extremely sensitive detection of Tb(III) chelates and also of biologically interesting compounds if these chelates are used as labels in bioaffinity assays. The suitability of silicon electrodes coated with thermally grown silicon dioxide film as disposable working electrodes in sensitive time-resolved ECL measurements is demonstrated, and a rapid electrochemiluminoimmunoassay (ECLIA) of human C-reactive protein (hCRP) is described. Th(III) chelate labels can be detected almost down to picomolar level, and the calibration curve of these labels covers more than 6 orders of magnitude of chelate concentration. The calibration curve of the present immunometric hCRP assay was found to be linear over a wide range, similar to 4 orders of magnitude of hCRP concentration, the detection limit of the protein being 0.3 ng mL(-1) (mean background + 2SD) on CV values of about 10-30%, depending on the immunoassay incubation time. In the ECLIA measurements, different incubation times were tested from 15 min (giving above-mentioned performance) to as short as only 2 min, which still gave successful results with similar to 20 000 times better detection limit levels than traditional commercial assay methods. During the ECLIA process, also the Si electrode surface morphology was also investigated by atomic force microscope monitoring.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 68 条
[61]  
Roberts WL, 2001, CLIN CHEM, V47, P418
[62]   SOLID-PHASE RADIOIMMUNOASSAYS FOR HUMAN C-REACTIVE PROTEIN [J].
SHINE, B ;
DEBEER, FC ;
PEPYS, MB .
CLINICA CHIMICA ACTA, 1981, 117 (01) :13-23
[63]   The physiological structure of human C-reactive protein and its complex with phosphocholine [J].
Thompson, D ;
Pepys, MB ;
Wood, SP .
STRUCTURE, 1999, 7 (02) :169-177
[64]   LANGMUIR-BLODGETT-FILMS OF IMMUNOGLOBULINES IGG - ELLIPSOMETRIC STUDY OF THE DEPOSITION PROCESS AND OF IMMUNOLOGICAL ACTIVITY [J].
TRONIN, A ;
DUBROVSKY, T ;
DENITTI, C ;
GUSSONI, A ;
EROKHIN, V ;
NICOLINI, C .
THIN SOLID FILMS, 1994, 238 (01) :127-132
[65]   C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree - The Rotterdam study [J].
van der Meer, IM ;
de Maat, MPM ;
Hak, AE ;
Kiliaan, AJ ;
del Sol, AI ;
van der Kuip, DAM ;
Nijhuis, RLG ;
Hofman, A ;
Witteman, JCM .
STROKE, 2002, 33 (12) :2750-2755
[66]   METABOLIC AND SCINTIGRAPHIC STUDIES OF RADIOIODINATED HUMAN C-REACTIVE PROTEIN IN HEALTH AND DISEASE [J].
VIGUSHIN, DM ;
PEPYS, MB ;
HAWKINS, PN .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1351-1357
[67]   Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation [J].
Walter, DH ;
Fichtlscherer, S ;
Britten, MB ;
Rosin, P ;
Auch-Schwelk, W ;
Schächinger, V ;
Zeiher, AM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) :2006-2012
[68]   C-reactive protein and angiographic coronary artery disease: Independent and additive predictors of risk in subjects with angina [J].
Zebrack, JS ;
Muhlestein, JB ;
Horne, BD ;
Anderson, JL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (04) :632-637